not tagged
seattle childrenâ€™s therapeutics
['solid tumor', 'car t', "seattle children's therapeutics"]
dr. katie albert: egfr806 directed car t cells have acceptable toxicity in patients with recurrent/refractory solid tumors and early signal of anti-tumor activity. #asco22
A non-profit therapeutics development enterprise, devoted to envisioning and testing next-generation cell and gene therapies for pediatric diseases.